Free Trial

P3 Health Partners (PIII) Competitors

P3 Health Partners logo
$7.27 -0.13 (-1.76%)
Closing price 07/25/2025 03:59 PM Eastern
Extended Trading
$7.36 +0.09 (+1.17%)
As of 07/25/2025 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PIII vs. XGN, DCGO, EUDA, SERA, QIPT, CORBF, NAKA, KDLY, ATPC, and BNR

Should you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include Exagen (XGN), DocGo (DCGO), EUDA Health (EUDA), Sera Prognostics (SERA), Quipt Home Medical (QIPT), Global Cord Blood (CORBF), KindlyMD (NAKA), Kindly MD (KDLY), Agape ATP (ATPC), and Burning Rock Biotech (BNR). These companies are all part of the "healthcare" industry.

P3 Health Partners vs. Its Competitors

Exagen (NASDAQ:XGN) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation and dividends.

In the previous week, Exagen had 6 more articles in the media than P3 Health Partners. MarketBeat recorded 8 mentions for Exagen and 2 mentions for P3 Health Partners. P3 Health Partners' average media sentiment score of 0.94 beat Exagen's score of 0.58 indicating that P3 Health Partners is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Exagen
1 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
P3 Health Partners
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

75.3% of Exagen shares are held by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are held by institutional investors. 12.6% of Exagen shares are held by insiders. Comparatively, 17.8% of P3 Health Partners shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Exagen has higher earnings, but lower revenue than P3 Health Partners. Exagen is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Exagen$56.72M2.73-$15.11M-$0.84-8.65
P3 Health Partners$1.50B0.03-$135.85M-$47.28-0.15

Exagen currently has a consensus price target of $9.00, indicating a potential upside of 23.80%. P3 Health Partners has a consensus price target of $16.25, indicating a potential upside of 123.52%. Given P3 Health Partners' higher probable upside, analysts plainly believe P3 Health Partners is more favorable than Exagen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Exagen
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00
P3 Health Partners
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

P3 Health Partners has a net margin of -9.27% compared to Exagen's net margin of -27.34%. P3 Health Partners' return on equity of -123.10% beat Exagen's return on equity.

Company Net Margins Return on Equity Return on Assets
Exagen-27.34% -133.69% -34.87%
P3 Health Partners -9.27%-123.10%-15.94%

Exagen has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500.

Summary

Exagen and P3 Health Partners tied by winning 8 of the 16 factors compared between the two stocks.

Get P3 Health Partners News Delivered to You Automatically

Sign up to receive the latest news and ratings for PIII and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PIII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PIII vs. The Competition

MetricP3 Health PartnersMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$53.19M$2.07B$5.70B$9.50B
Dividend YieldN/AN/A4.58%4.01%
P/E Ratio-0.1537.0728.4120.08
Price / Sales0.0311.17432.3189.32
Price / CashN/A55.2536.2258.56
Price / Book0.699.108.675.88
Net Income-$135.85M-$63.59M$3.25B$258.89M
7 Day Performance9.98%3.16%4.25%3.71%
1 Month Performance17.92%10.15%10.51%11.72%
1 Year Performance-76.56%6.21%35.68%18.01%

P3 Health Partners Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PIII
P3 Health Partners
3.1003 of 5 stars
$7.27
-1.8%
$16.25
+123.5%
-76.2%$53.19M$1.50B-0.15500
XGN
Exagen
4.1808 of 5 stars
$6.97
-0.4%
$7.50
+7.6%
+258.1%$149.10M$55.64M-8.30220News Coverage
Upcoming Earnings
Analyst Forecast
DCGO
DocGo
2.059 of 5 stars
$1.42
-0.7%
$3.56
+150.7%
-58.9%$145.84M$616.55M-71.004,407News Coverage
Positive News
EUDA
EUDA Health
0.9069 of 5 stars
$3.09
-1.9%
N/A-17.8%$117.23M$4.01M0.002Upcoming Earnings
Gap Down
SERA
Sera Prognostics
0.7237 of 5 stars
$2.92
flat
N/A-59.5%$110M$80K-3.11120
QIPT
Quipt Home Medical
2.9902 of 5 stars
$2.02
-3.3%
$2.85
+41.1%
-40.7%$90.80M$245.91M-9.621,200
CORBF
Global Cord Blood
N/A$0.55
+0.1%
N/A-47.4%$66.91M$196.12M0.001,200Gap Up
NAKA
KindlyMD
N/A$10.95
-0.6%
N/AN/A$66.45M$2.72M-14.22N/A
KDLY
Kindly MD
N/A$11.02
-3.6%
N/A+453.3%$66.36M$2.47M-14.31N/A
ATPC
Agape ATP
0.8595 of 5 stars
$1.30
+0.8%
N/A-40.8%$64.51M$1.32M-2.1740Positive News
BNR
Burning Rock Biotech
1.6415 of 5 stars
$4.93
+4.8%
N/A+0.9%$50.58M$70.67M-2.611,390Positive News

Related Companies and Tools


This page (NASDAQ:PIII) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners